Expression analysis of CK1α in melanoma datasets clearly revealed a reduction in mRNA expression during melanoma progression and we could confirm the reduction of CK1α expression in metastatic melanoma cells on RNA and protein level [4, 9]. This evidence concerns the gene CSNK1A1 and metastatic melanoma.